Drug profile · INN
nitroglycerin
GONITRO
nitroglycerin (GONITRO) is a soluble guanylate cyclase activator. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intra-anal. Current US regulatory status: approved.
Drug details — nitroglycerin
- US status
- approved
- Class
- —
- Route
- INTRA-ANAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
nitroglycerin (GONITRO) is a soluble guanylate cyclase activator. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intra-anal. Current US regulatory status: approved.
Key facts
Mechanism of action
Soluble guanylate cyclase activator
Primary target: Soluble guanylate cyclase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nitroglycerin?
nitroglycerin (GONITRO) is a soluble guanylate cyclase activator. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intra-anal. Current US regulatory status: approved.
What is the brand name for nitroglycerin?
GONITRO is a marketed brand name for nitroglycerin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nitroglycerin?
nitroglycerin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.